JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, presented results from an expanded cohort of 500 patients in the ALIGN-AR Pivotal Trial ...
Still, they face challenges due to missing or invalid recordings caused by technical issues. To address this, we introduce a novel framework leveraging the masked autoencoder strategy, uniquely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback